Literature DB >> 2014293

Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.

E A Sickles1.   

Abstract

The author prospectively evaluated the value of periodic mammographic surveillance among 3,184 consecutive cases of nonpalpable, probably benign breast lesions detected with mammography. Follow-up consisted of four mammographic examinations during a 3- or 3.5-year period. Clinical outcome was ascertained in each case after the study period, whether or not patients complied with the protocol. Probably benign lesions were subsequently found to be malignant in 17 cases (positive predictive value for cancer, 0.5%). Fifteen of the 17 cancers were identified by means of interval mammographic change prior to development of a palpable mass; all 17 were stage 0 or stage 1 tumors. All 17 women who had cancer currently show no evidence of tumor recurrence (median duration of follow-up, 5 years). These results should help establish the validity of managing mammographically detected, probably benign lesions with periodic mammographic surveillance. By decreasing the number of biopsies of benign lesions and thereby substantially reducing costs, this approach may help overcome a major barrier to widespread use of mammographic screening.

Entities:  

Mesh:

Year:  1991        PMID: 2014293     DOI: 10.1148/radiology.179.2.2014293

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  57 in total

1.  Computer-aided classification of breast masses: performance and interobserver variability of expert radiologists versus residents.

Authors:  Swatee Singh; Jeff Maxwell; Jay A Baker; Jennifer L Nicholas; Joseph Y Lo
Journal:  Radiology       Date:  2010-10-22       Impact factor: 11.105

2.  Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Authors:  Susan P Weinstein; Lucy G Hanna; Constantine Gatsonis; Mitchell D Schnall; Mark A Rosen; Constance D Lehman
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Optimization of contrast-enhanced spectral mammography depending on clinical indication.

Authors:  Clarisse Dromain; Sandra Canale; Sylvie Saab-Puong; Ann-Katherine Carton; Serge Muller; Eva Maria Fallenberg
Journal:  J Med Imaging (Bellingham)       Date:  2014-12-30

4.  Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.

Authors:  Hye Mi Gweon; Nariya Cho; Soo-Yeon Kim; Hye Ryoung Koo; Mirinae Seo; Ajung Chu; Eun Ju Son
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

5.  Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy.

Authors:  Amy Lynn Conners; Carrie B Hruska; Cindy L Tortorelli; Robert W Maxwell; Deborah J Rhodes; Judy C Boughey; Wendie A Berg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06       Impact factor: 9.236

Review 6.  Applications and literature review of the BI-RADS classification.

Authors:  S Obenauer; K P Hermann; E Grabbe
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

7.  Knowledge discovery from structured mammography reports using inductive logic programming.

Authors:  Elizabeth S Burnside; Jesse Davis; Victor Santos Costa; Inês de Castro Dutra; Charles E Kahn; Jason Fine; David Page
Journal:  AMIA Annu Symp Proc       Date:  2005

8.  [Evaluation of the results after using of the BI-RADS categories in 1,777 clinical mammograms].

Authors:  E A Hauth; K Khan; B Wolfgarten; A Betzler; R Kimmig; M Forsting
Journal:  Radiologe       Date:  2008-03       Impact factor: 0.635

9.  Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.

Authors:  Su Min Ha; Eun Young Chae; Joo Hee Cha; Hee Jung Shin; Woo Jung Choi; Hak Hee Kim
Journal:  Br J Radiol       Date:  2018-04-25       Impact factor: 3.039

10.  Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.

Authors:  C Walter; K Scheidhauer; A Scharl; U-J Goering; P Theissen; H Kugel; T Krahe; U Pietrzyk
Journal:  Eur Radiol       Date:  2003-01-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.